Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Experience with 1,000 Patients-Reference-Cited by-同舟云学术

Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Experience with 1,000 Patients

Published:2014-04 Issue:4 Volume:218 Page:573-585
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:Journal of the American College of Surgeons

Author:

Levine Edward A.,Stewart John H.,Shen Perry,Russell Gregory B.,Loggie Brian L.,Votanopoulos Konstantinos I.

Publisher

Elsevier BV

Subject

Surgery

Reference83 articles.

1. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study;Sadeghi;Cancer,2000

2. Peritonectomy procedures;Sugarbaker;Ann Surg,1995

3. New approach to management of malignant ascitis with a streptococcal preparation OK 432: improvement of host immunity and prolongation of survival;Torisu;Surgery,1983

4. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors;Hendren;Ann Surg Oncol,2001

5. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study;Sindelar;Arch Surg,1991

Cited by 218 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experience;International Journal of Gynecologic Cancer;2023-11-27

2. Quality-of-Life Outcomes for Patients Taking Opioids and Psychotropic Medications Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Annals of Surgical Oncology;2023-10-27

3. Analysis of Intraoperative Variables Responsible for the Increase in Lactic Acid in Patients Undergoing Debulking Surgery;Journal of Personalized Medicine;2023-10-26

4. Standardised Critical Care Strategies Improve Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in an Indian Peritoneal Malignancy Centre;Indian Journal of Surgical Oncology;2023-08-07

5. Cisplatin exhibits superiority over MMC as a perfusion agent in a peritoneal mesothelioma patient specific organoid HIPEC platform;Scientific Reports;2023-07-19